Skip to content

Alnylam Pharmaceuticals Inc Aktienkurs

Alnylam Pharmaceuticals Inc Aktienkurs

Infórmate sobre cómo es trabajar en Alnylam Pharmaceuticals. Regístrate en LinkedIn gratis hoy mismo. Averigua a quién conoces en Alnylam Pharmaceuticals, obtén el máximo beneficio de tu red y … Alnylam technically has 5 core values, but the only one that matters is Sense of Urgency. People work 24/7, including weekends and during their vacation, and Senior Leadership model this behavior. The environment is so tense and cutthroat that people throw each other under the bus, instead of … Dowiedz się więcej o pracy w Alnylam Pharmaceuticals Dołącz dzisiaj bezpłatnie do LinkedIn. Zobacz, kogo znasz w Alnylam Pharmaceuticals, wykorzystaj swoją sieć … Alnylam Pharmaceuticals and Ionis Pharmaceuticals toppled Thursday after Dow Jones component Pfizer unveiled strong late-stage results for a competing rare-disease drug. X. Shares of Alnylam plunged 8.3% to 119.10 at the close, hitting their lowest point since Feb. 9. Ionis stock tumbled to a seven-month low, closing down 4%, at 44.08.

Alnylam Pharmaceuticalsの求人をチェックしましょう。今すぐLinkedInに登録しましょう。Alnylam Pharmaceuticalsの知り合いと通じてキャリアアップを図りましょう。

Alnylam Pharmaceuticals Aktie: Aktueller Aktienkurs ✓ Charts ✓ Nachrichten ✓ Realtime ✓ WKN: A0CBCK | ISIN: US02043Q1076. ALNYLAM PHARMACEUTICALS AKTIE (ISIN: US02043Q1076): ✓ Realtime-Kurs der Alnylam Pharmaceuticals Aktie, ✓ Dividenden-Rendite und Termine,  Zu der Alnylam Pharmaceuticals Aktie (WKN A0CBCK, ISIN US02043Q1076) finden Sie hier: Analysen, News, Kurse, Charts, Diskussionen, Få detaljerad information om Alnylam Pharmaceuticals Inc (ALNY) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Alnylam rapporter och mycket 

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi 

Alnylam Pharmaceuticals has 1,065 employees across 3 locations and $74.91 M in annual revenue in FY 2018. See insights on Alnylam Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. En savoir plus sur l’actualité professionnelle de Alnylam Pharmaceuticals. Inscrivez-vous sur LinkedIn gratuitement. Découvrez qui vous connaissez chez Alnylam Pharmaceuticals, utilisez votre réseau professionnel et faites-vous embaucher. Erfahren Sie mehr darüber, wie es ist, bei Alnylam Pharmaceuticals zu arbeiten. Melden Sie sich noch heute bei LinkedIn an – völlig kostenlos. Entdecken Sie, wen Sie bei Alnylam Pharmaceuticals kennen, nutzen Sie Ihr berufliches Netzwerk und finden Sie in diesem Unternehmen eine Stelle. 31/10/2019 · Alnylam Named #1 Biopharma Employer by Science Magazine. 10/24/2019. Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that Science magazine has named the company the world’s number one employer in its annual survey of the biotech and pharmaceutical industry.

30/10/2019 · Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts. View our full ALNY ticker page with ratings, news, and more.

Meer informatie over hoe het is om bij Alnylam Pharmaceuticals te werken. Word vandaag gratis lid van LinkedIn. Bekijk wie u kent bij Alnylam Pharmaceuticals, benut uw professionele netwerk en zorg dat u wordt aangenomen. Scopri i dettagli delle offerte di lavoro presso Alnylam Pharmaceuticals. Iscriviti subito a LinkedIn. È gratis! Scopri chi conosci presso Alnylam Pharmaceuticals, sfrutta la … Alnylam Pharmaceuticals, Inc. (ALNY) Quote Overview » Charts » Alnylam Pharmaceuticals, Inc. (ALNY) Fundamental Charts Price Fundamental Charts The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Infórmate sobre cómo es trabajar en Alnylam Pharmaceuticals. Regístrate en LinkedIn gratis hoy mismo. Averigua a quién conoces en Alnylam Pharmaceuticals, obtén el … 07/09/2003 · Alnylam Pharmaceuticals develops novel therapeutics-based RNAi and provides overviews of Active Funding Status IPO Last Funding Type Post-IPO Equity Number of Employees 251-500 Also Known As Alnylam Legal Name ALNYLAM Pharmaceuticals, Inc. Alnylam is developing an entirely new class of innovative medicines based on a breakthrough 02/10/2019 · ALNY had returned +0.54% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period. More Info About Alnylam Pharmaceuticals, … Aflați mai multe despre munca la Alnylam Pharmaceuticals. Aderați astăzi la LinkedIn gratuit. Vizualizați persoanele cunoscute de la Alnylam Pharmaceuticals, folosiți rețeaua dvs. profesională și angajați-vă.

Aflați mai multe despre munca la Alnylam Pharmaceuticals. Aderați astăzi la LinkedIn gratuit. Vizualizați persoanele cunoscute de la Alnylam Pharmaceuticals, folosiți rețeaua dvs. profesională și angajați-vă.

Alnylam Pharmaceuticalsの求人をチェックしましょう。今すぐLinkedInに登録しましょう。Alnylam Pharmaceuticalsの知り合いと通じてキャリアアップを図りましょう。

Apex Business WordPress Theme | Designed by Crafthemes